Polyomavirus- Associated Human Cancers
Polyomavirus- Associated Human Cancers
批准号:
7897082
负责人:
Yu-Tsueng Liu
金额:
$20.16万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2012-03-31
关键词:
AdultAnimal ModelAnimalsAntibodiesAntigensAustraliaBiological AssayBiological MarkersBloodCDKN2A geneCancer CenterCancer EtiologyCancer PatientCase-Control StudiesCell Culture TechniquesCellsChronic Lymphocytic LeukemiaCollectionConsentControlled StudyCross-Sectional StudiesCutaneousDNADevelopmentDiagnosticDiseaseEpidemiologic StudiesEpidemiologyEuropeFamily memberGastrointestinal NeoplasmsGastrointestinal tract structureGeneral PopulationGoalsHandHepatitis BHepatitis B VirusHepatitis CHerpesviridaeHumanHuman Herpesvirus 4Human Herpesvirus 8Human PapillomavirusHuman T-lymphotropic virus 1Human VirusImmunoassayImmunohistochemistryImmunosuppressionIncidenceInfectionKaposi SarcomaLarge T AntigenLinkLungLymphomaMalignant NeoplasmsMalignant neoplasm of prostateMerkel CellsMerkel cell carcinomaMolecularNamesNorth AmericaOncogenicOncogenic VirusesOutcomePathologyPatientsPlasmaPlasmacytic LeukemiaPlayPolyomavirusPredisposing FactorPrimary carcinoma of the liver cellsPrognostic MarkerReagentReportingResearchResearch Ethics CommitteesResource SharingResourcesRoleSamplingScreening procedureSecond Primary CancersSeroepidemiologic StudiesSerologicalSerumSkinSourceStaining methodStainsSun ExposureT-LymphocyteTestingTissue Array Research ProgramTissue MicroarrayTissuesTumor AntibodiesTumor TissueVirusVirus Integrationbasebiobankcancer preventioncancer typecase controlcell transformationcohortdesignexperiencehigh riskinterestmalignant breast neoplasmneoplastic cellpatient populationprognosticpublic health relevancetherapeutic targettumorvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): While polyomaviruses can induce cell transformation in cell culture and in animal models, their role in causing human cancers has been controversial. A new member of this family, named Merkel cell polyomavirus (MCV) was reported to be a potential etiological agent for the rare Merkel cell carcinoma (MCC) in early 2008. Subsequently, high incidence of MCV in MCC was confirmed with samples from North America, Europe and Australia. MCV appears to be present in 8-16% of control samples with very low copy number in various tissues of gastrointestinal tract and skin, compared to 80% of Merkel cell cancer samples. Such phenomenon is also documented in other known human oncogenic viruses. In addition, a number of oncogenic viruses cause more than one type of cancer. For example, herpesvirus-8 (HHV-8)/Kaposi's sarcoma herpesvirus (KSHV) causes Kaposi's sarcoma, lymphoma and other diseases. Interestingly, Merkel cell carcinoma and Kaposi's sarcoma share a similar epidemiological profile. Therefore, we hypothesize that MCV is also associated with other cancers in additional to the Merkel cell tumor. We are also interested in finding if the other known and unknown polyomaviruses are also associated with cancer development. To achieve these goals, we will create a variety of reagents and assays to determine the involvement of human polyomaviruses, particularly MCV, in different types of cancers. Our specific aims are 1. Developing MCV immunoassays for seroepidimiological studies and MCV-specific antibodies for cancer immunohistochemical analyses. 2. Identifying polyomaviruses in cancer with a comprehensive array-based assay; 3. Using a case-control design, establish preliminary seroepidemiologic evidence for or against MCV as a causal agent in a spectrum of cancers. Once establishing the etiological role of the virus, we will potentially use this virus as a diagnostic and prognostic biomarker and as a potential therapeutic target. These longer term goals have been successfully demonstrated in other oncogenic viruses, such as hepatitis B virus and human papillomaviruses.
PUBLIC HEALTH RELEVANCE: Polyomavirus- Associated Human Cancers A recently discovered virus, named Merkel cell polyomavirus (MCV), may become the 7th bona fide human cancer-causing virus. This study aims to investigate the association of this virus and various types of cancer and to evaluate the use of this virus as a diagnostic and prognostic marker. A potential long term goal is to develop a vaccine targeting MCV for cancer prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
High quality CTC isolation using microbubbles for downstream molecular analysis
-
批准号:8737211
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2013
-
负责人:Yu-Tsueng Liu
-
依托单位:
High quality CTC isolation using microbubbles for downstream molecular analysis
-
批准号:8915098
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2013
-
负责人:Yu-Tsueng Liu
-
依托单位:
High quality CTC isolation using microbubbles for downstream molecular analysis
-
批准号:8624981
-
项目类别:
-
资助金额:$32.86万
-
财政年份:2013
-
负责人:Yu-Tsueng Liu
-
依托单位:
Non-invasive sampling of DNA markers for pancreatic cancer screening
-
批准号:8435334
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2012
-
负责人:Yu-Tsueng Liu
-
依托单位:
Polyomavirus-Associated Human Cancers
-
批准号:8035407
-
项目类别:
-
资助金额:$16.3万
-
财政年份:2010
-
负责人:Yu-Tsueng Liu
-
依托单位:
Prostate Fusion Gene Variants as a Cancer Biomarker
-
批准号:7586685
-
项目类别:
-
资助金额:$20.86万
-
财政年份:2008
-
负责人:Yu-Tsueng Liu
-
依托单位:
Prostate Fusion Gene Variants as a Cancer Biomarker
-
批准号:7450700
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2008
-
负责人:Yu-Tsueng Liu
-
依托单位:
海外基金